BANJA LUKA (Bosnia and Herzegovina), January 21 (SeeNews) – Serbian drug maker Hemofarm, a unit of Germany's Stada, plans to invest 22 million euro ($25.5 million) in its production plants in Serbia, Bosnia and Montenegro this year, Belgrade-based media reported on Wednesday.